Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

NIH Awards Contract for Management of Biocontainment Facility at Fort Detrick

by Stephanie Lizotte
May 13, 2018
Biodefense Funding Contract Awards

The National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) is part of the National Interagency Biodefense Campus based at Fort Detrick, Maryland.

Under a new contract worth up to $131,306,342 the IRF will be managed and operated by Laulima Government Solutions LLC

The NIAID IRF is a biosafety level 4 (BSL-4) specialized biocontainment facility supporting basic research and animal studies on various infectious disease agents to evaluate therapeutics, vaccines and diagnostics as well as natural history and pathogenesis associated with these agents.

Scientists at the IRF focus intensively on developing prevention and treatment options that will be directly relevant to naturally occurring or deliberately introduced human diseases. IRF Staff may be required at times to deploy to infectious disease outbreak sites in support of NIAID DCR clinical protocols around the world.

Highlighted activities supported by the contract include:

  • Clinical Core Services of Molecular Biology, Immunology, Virology, Cell Culture
  • Aerobiology
  • Imaging Physics with emphasis on Magnetic Resonance Imaging (MRI), Computed tomography (CT); Single Positron Emission Computed Tomography (SPECT); Positron Emission Tomography (PET) and Ultrasonography
  • Outbreak Laboratory Support deployment to international and domestic sites
  • Comparative Medicine and Animal Care and Technical Support at IRF
  • Administrative Management and Operations inclusive of:
  • Training
  • Programmatic and Logistical Support

Additional details are available at FBO.gov (#HHSN272201800013C).

Tags: AwardsBiosafetyNIAID

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC